About FDA
Average American Customer Satisfaction Index (ACSI) evaluation score from surveys completed on the mobile site during the month
Dictionary: The American Customer Satisfaction Index (ACSI) is a comprehensive reflection of the citizen experience with federal government websites, and it serves as a critical checkpoint for evaluating the success and performance of the federal government’s online initiatives. Visitors to federal government websites are randomly presented with online satisfaction surveys when navigating through the sites and the survey assigns an overall customer satisfaction score based on several individual elements that comprise satisfaction, like content, search, navigation, and site performance. For 2013, FDA received over 9800 completed surveys. This demonstrates that citizens are willing to share their voices to help FDA improve. The use of the ACSI methodology and technology then enables agency leaders to determine which website improvements will have the greatest impact on future usage and recommendations. An ACSI score of 72 is the average score for federal agencies.
Information is current as of September 30, 2018
Fiscal Year - 2018
Time | Target | Average |
---|---|---|
Oct 2017 | N/A | 76 |
Nov 2017 | N/A | 74 |
Dec 2017 | N/A | 75 |
Jan 2018 | N/A | 76 |
Feb 2018 | N/A | 76 |
Mar 2018 | N/A | 76 |
Apr 2018 | N/A | 73 |
May 2018 | N/A | 74 |
Jun 2018 | N/A | 74 |
Jul 2018 | N/A | N/A |
Aug 2018 | N/A | N/A |
Sep 2018 | N/A | N/A |
FY 2018 Total: 74
Footnotes
- OEA is transitioning to a new system as of July 2018. New data measuring the average consumer satisfaction index is unavailable in Fiscal Year 18 Quarter 4.
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.